Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID‐19‐associated organ failure

Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID‐19‐associated organ failure

Abstract The use of mesenchymal stem cells (MSC) derived from several sources has been suggested as a major anti‐inflammation strategy during the recent outbreak of coronavirus‐19 (COVID‐19). As the virus enters the target cells through the receptor ACE2, it is important to determine if the MSC popu...

Full description

Bibliographic Details
Main Authors: Christophe Desterke, Frank Griscelli, Jusuf Imeri, Paul Marcoux, Thomas Lemonnier, Theodoros Latsis, Ali G. Turhan, Annelise Bennaceur‐Griscelli
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Stem Cells Translational Medicine
Subjects:
adult human bone marrow
embryonic stem cells
induced pluripotent stem cells
lymphocytes
mesenchymal stem cells
Online Access:https://doi.org/10.1002/sctm.20-0189

Similar Items

Similar Items